Drug Profile
W 13
Latest Information Update: 26 Jul 1994
Price :
$50
*
At a glance
- Originator Unknown
- Class Antineoplastics
- Mechanism of Action Calmodulin antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Breast cancer